ArticleAmerican journal of translational research2025
Low-intensity ultrasound stimulation promotes differentiation of bone marrow mononuclear cells to nucleus pulposus cells for matrix synthesis.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the role of low-intensity ultrasound stimulation (LIUS) in facilitating the differentiation of bone marrow mononuclear cells (BMMNCs) into nucleus pulposus cells (NPCs) for matrix synthesis, offering a possible new therapeutic approach for intervertebral disc degeneration.
methodsHuman BMMNCs and NPCs were cultured, and exosomes were extracted from NPCs using differential ultracentrifugation, followed by characterization. LIUS was utilized to evaluate exosome uptake, induce cell differentiation, measure apoptosis, and track DNA synthesis by EdU assays. Various experimental conditions were tested, including different LIUS intensities and differentiation durations. A range of detection techniques, such as RT-qPCR, western blotting, and cellular staining, were employed to monitor relevant indicators.
resultsExosomes were successfully isolated from NPCs, and their purity was confirmed using nanoparticle tracking analysis (NTA), transmission electron microscopy, and western blot. PKH67-labeled exosomes were internalized by BMMNCs during co-incubation. LIUS treatment at different intensities revealed that the LIUS-100 group exhibited the most significant cell proliferation, as shown by EdU assays. Flow cytometry revealed that the LIUS-100 and LIUS-150 groups demonstrated the most pronounced inhibition of apoptosis. In NPC exosome-induced differentiation experiments, the expression of relevant marker mRNA and protein levels increased over time under standard conditions, with even greater upregulation observed under LIUS-100 stimulation. Moreover, LIUS-100 enhanced the intracellular accumulation of glycosaminoglycans and proteoglycans, suggesting its role in promoting BMMNC differentiation into NPCs and matrix component synthesis.
conclusionNPC exosomes and LIUS are essential for guiding the differentiation of BMMNCs into NPCs, representing a promising therapeutic strategy for intervertebral disc degeneration. However, further
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.